Diabetes Obes Metab 19(10):13531362
These metabolic shifts were significantly related to changes in body weight, abdominal fat, and measures of insulin sensitivity and lipid metabolism
After announcing the state would initiate coverage of GLP-1s to combat obesity in September 2022 as part of their state employee health plan, the state reversed course and in January 2025 announced it was opting to end that coverage beginning July 1, 2025
"Metformin monotherapy for adults with type 2 diabetes mellitus"
During your consultation, well assess your skin, discuss your aesthetic goals, and create a personalized treatment plan designed to help you achieve natural-looking, lasting results
Rapid weight loss, whether from GLP-1 medications or other causes, can affect mineral stores through reduced intake, altered absorption, and changes in body composition that release stored minerals